380. Urology: MRI-native robotic platform for prostate cancer with Fazila Seker, CEO of Insight Medbotics

In this episode, Omar Khateeb sits down with Fazila Seker, CEO and Board Director of Insight Medbotics, to explore how meaningful MedTech innovation starts by solving real clinical problems.Fazila shares how her team uncovered a major gap in prostate cancer care by closely observing how physicians use MRI today. That insight led to the development of an MRI-native platform designed to unify diagnosis and treatment into one precise workflow.The conversation covers the limitations of fusion-based systems, the value of exact spatial data, and how a connected data layer can improve targeting, outcomes, and future AI-driven insights.A sharp look at how market-driven thinking turns clinical needs into real innovation.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown:00:00 Why MRI Could Transform Prostate Cancer Care01:08 Intro + Fazila Seker Background01:54 From PhD Chemist to MedTech Founder03:41 Why Healthcare Innovation Matters More04:53 Why MedTech is Harder Than Tech Startups06:14 Fall in Love With the Customer, Not the Technology07:10 Why Physicians Resist New Technology07:57 Building Molli Surgical Through Market Validation09:18 Molli Surgical Explained11:23 Getting Acquired Before FDA Clearance13:58 Why Most MedTech Startups Fail After FDA15:52 Market Engineering vs Traditional Go-To-Market17:27 Why Market Pull Matters in MedTech18:28 Inside Insight Medbotics20:39 Why MRI Native Robotics Matters22:57 MRI Limitations in Prostate Cancer Today23:33 Product-Market Fit vs Market-Product Fit24:40 Physician “Hacks” Reveal Market Opportunities32:22 Why Fusion Imaging Falls Short33:43 FDA Challenges of MRI Robotics34:22 Diagnosis + Treatment in One Platform35:25 Building a Closed-Loop MRI Data Platform36:29 The Future AI Layer for Predictive Care37:56 GPS for Prostate Cancer Explained40:22 Strategic Partners: Intuitive, J&J, Medtronic42:40 Future of Drug Delivery and Precision Oncology44:10 Transformative Innovation vs Incremental MedTech45:49 Why Healthcare Rewards Incremental Innovation50:14 Why Startups Fail Without Market Need51:20 The Problem With “Me Too” MedTech Companies53:25 Why Transformational Thinking Wins54:13 Fundraising, AUA, and What’s Next for Insight55:50 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #prostatecancer #medicalimaging #healthcareinnovation #surgicalrobotics